Batch of 2017

Alter Ego is a browser button that protects your identity from the bad guys around the net. It generates aliases for your email address, military strong passwords and any other personal data a site may require. These IDs are linked to your email so you can forget about the ‘spam email address’ or worry about your credentials being stolen.

BOX2M is a Romanian start-up focused on industrial IOT, aiming design and production of devices and deployment of specialized software. Business wise, BOX2M has a B2B model with energy, telecom, security and utilities sectors and works with infrastructure operators, service suppliers and system integrators.

CoinFlux is an online exchange service for cryptocurrencies, including bitcoin, ether and litecoin. We make it easy for clients to quickly buy and sell coins via bank transfer.

Engager is the employee engagement app for knowledge workers in medium and large sized companies.

FeedCheck brings all product reviews in one place in order to analyze them and provide valuable insights for the consumer brands. No matter where the products are sold, FeedCheck collects all reviews from Amazon, eBay, Target and many other online stores.

Froala helps developers build and edit beautiful websites with products focused on UX, innovation and customer care.

PixTeller is an online tool that improves and simplifies the design process from start to end. It is easy to use for everyone for personal or business purposes, even with no technical or design knowledge.

Profluo is an emerging Digital Business Platform that helps small and medium enterprises continuously (re)define and execute, through a combination of business processes and business data, their entire business model.

Road Grand Tours is a multiplayer online world where cyclists can explore the world greatest roads and participate in mass events, just by using their own bikes and smart trainers at home.

Symme3D Biotech is the first independent producer with 100% Romanian capital that develops a 3D printing machine for various avascular living tissue and blood vessels from stem cells, as well as cancerous tumours, with the aim to the aid in personalising cancer therapies. Symme3D Biotech’s first product will be launched at MedTec Europe, in Stuttgart, on 4th to 6th April.